Oral Drug Safe, Effective in Kids With Achondroplasia

(MedPage Today) -- The oral FGFR1-3 selective tyrosine kinase inhibitor infigratinib was found to be safe and effective at the highest studied dose among children with achondroplasia in a phase II dose-finding study.
During treatment, all 72 participants...